标题
Acute myeloid leukemia in older adults
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume 96, Issue 2, Pages 186-193
出版商
Springer Nature
发表日期
2012-07-12
DOI
10.1007/s12185-012-1137-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Acute Myeloid Leukemia
- (2017) Margaret R. O'Donnell et al. Journal of the National Comprehensive Cancer Network
- Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-HOCS)
- (2012) Kumi Oshima et al. ANNALS OF HEMATOLOGY
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 Study
- (2012) Atsushi Wakita et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- Acute myeloid leukaemia in the elderly: a review
- (2011) Daniel A. Pollyea et al. BRITISH JOURNAL OF HAEMATOLOGY
- The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome
- (2011) A K Burnett et al. LEUKEMIA
- Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutations
- (2011) Harshabad Singh et al. LEUKEMIA RESEARCH
- FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
- (2010) S. P. Whitman et al. BLOOD
- Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study
- (2010) B. Lowenberg et al. BLOOD
- Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999
- (2010) L. D. Cripe et al. BLOOD
- A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial
- (2010) C. Rollig et al. BLOOD
- Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome
- (2010) Brian L. McClune et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Study of Intensified Anthracycline Doses for Induction and Recombinant Interleukin-2 for Maintenance in Patients With Acute Myeloid Leukemia Age 50 to 70 Years: Results of the ALFA-9801 Study
- (2010) Cecile Pautas et al. JOURNAL OF CLINICAL ONCOLOGY
- AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significance
- (2009) H. J. M. de Jonge et al. BLOOD
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older
- (2009) J.-L. Harousseau et al. BLOOD
- The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial
- (2009) Alan K. Burnett et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials
- (2009) Keith Wheatley et al. BRITISH JOURNAL OF HAEMATOLOGY
- Age-Specific Differences in Oncogenic Pathway Dysregulation in Patients With Acute Myeloid Leukemia
- (2009) Arati V. Rao et al. JOURNAL OF CLINICAL ONCOLOGY
- Favorable Prognostic Impact ofNPM1Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study
- (2009) Heiko Becker et al. JOURNAL OF CLINICAL ONCOLOGY
- High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
- (2009) Bob Löwenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
- (2008) G. Juliusson et al. BLOOD
- Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005
- (2008) A. R. Derolf et al. BLOOD
- Liposomal daunorubicinversusstandard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia
- (2008) Roberto Latagliata et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia
- (2008) Sebastian Scholl et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century
- (2008) D. Pulte et al. HAEMATOLOGICA
- Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia
- (2008) J.-V. Malfuson et al. HAEMATOLOGICA
- Acute Myeloid Leukemia in the Elderly
- (2008) Hervé Dombret et al. SEMINARS IN ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now